Global Systemic Lupus Erythematosus (SLE) Drugs Market 2015-2019 is a new market research publication announced by Reportstack. SLE is the most common form of lupus and is also called lupus. It is a chronic, autoimmune disease with signs and symptoms that can last for six months or for many years. It can affect any part of the body, such as the skin, joints, and organs (LFA, 2012). SLE occurs when the immune system produces autoantibodies, which attack and destroy healthy tissues in the body rather than foreign infectious agents. These autoantibodies cause inflammation, pain, and damage. It is also known as a disease of flare-ups and remissions and can range from mild to life threatening in severity. No cure for SLE yet exists.
The analysts forecast the Global SLE Drugs market is expected to grow at a CAGR of 22.41 percent over the period 2014-2019.
This report covers the present scenario and the growth prospects of the Global SLE Drugs market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs used in the treatment of SLE that are available in the market.
The report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA; it covers the Global SLE Drugs market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market..
To access full report with TOC, please visit Global Systemic Lupus Erythematosus (SLE) Drugs Market 2015-2019
Key Regions
• Americas
• APAC
• EMEA
Key Vendors
• Anthera Pharmaceuticals
• BMS
• GSK
• ImmuPharma
• Merck Serono
• UCB
Other Prominent Vendors
• Amgen
• HGS
• Immunomedics
• Johnson & Johnson
• MedImmune
• Sanofi
• Teva Pharmaceutical Industries
Market Driver
• High Prevalence of Autoimmune Disease
• For a full, detailed list, view our report
Market Challenge
• Complex Etiology
• For a full, detailed list, view our report
Market Trend
• Increase in Awareness
• For a full, detailed list, view our report
Key Questions Answered in this Report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
The analysts forecast the Global SLE Drugs market is expected to grow at a CAGR of 22.41 percent over the period 2014-2019.
This report covers the present scenario and the growth prospects of the Global SLE Drugs market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs used in the treatment of SLE that are available in the market.
The report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA; it covers the Global SLE Drugs market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market..
To access full report with TOC, please visit Global Systemic Lupus Erythematosus (SLE) Drugs Market 2015-2019
Key Regions
• Americas
• APAC
• EMEA
Key Vendors
• Anthera Pharmaceuticals
• BMS
• GSK
• ImmuPharma
• Merck Serono
• UCB
Other Prominent Vendors
• Amgen
• HGS
• Immunomedics
• Johnson & Johnson
• MedImmune
• Sanofi
• Teva Pharmaceutical Industries
Market Driver
• High Prevalence of Autoimmune Disease
• For a full, detailed list, view our report
Market Challenge
• Complex Etiology
• For a full, detailed list, view our report
Market Trend
• Increase in Awareness
• For a full, detailed list, view our report
Key Questions Answered in this Report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
About Reportstack:
Reportstack is one of the leading distributors of market research reports in
the world today. We host more than 200,000 research products from the world's
top publication houses. These publications are distributed amongst 12 top
industry verticals and 62 sub verticals, which are then further classified into
257 business categories and 5000 micro markets. The vast selection criterion
provides granular data from the length and breadth of all these industries
delivering Reportstack members with cutting edge research products to
facilitate strategic business decisions.
Contact:
Debora White
Manager - Marketing
debora@reportstack.com
Ph: +1-888-789-6604
Reportstack Market Research
Manager - Marketing
debora@reportstack.com
Ph: +1-888-789-6604
Reportstack Market Research
No comments:
Post a Comment